Formulated for menopausal symptoms to manage hormonal balance and support bone health.
Mechanism of Action
Conjugated estrogens bind to estrogen receptors in target tissues, regulating gene transcription. This replaces declining natural estrogen levels, relieving vasomotor symptoms and maintaining vaginal and bone health in postmenopausal women.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
History of thromboembolic disorders, Breast cancer, Estrogen-dependent neoplasia, Undiagnosed uterine bleeding, Pregnancy
Severe Adverse Events
Endometrial cancer, Pulmonary embolism, Stroke — requires immediate medical attention
Information related to Conjugated Estrogens is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
